Description

PEG-MGF represents a modified form of Mechano Growth Factor incorporating polyethylene glycol (PEG) conjugation to enhance stability and extend biological half-life. The pegylation process involves covalent attachment of PEG molecules to the peptide, resulting in improved pharmacokinetic properties while maintaining the essential biological activities of the native MGF sequence. This modification makes PEG-MGF particularly suitable for research protocols requiring sustained growth factor activity and extended experimental timeframes. The compound retains the unique E-domain characteristics of MGF while providing enhanced stability for investigating mechanotransduction pathways, cellular proliferation mechanisms, and tissue repair processes. Research applications include extended studies of cellular biology, mechanosensitive signaling, and tissue engineering applications requiring prolonged growth factor exposure. For research use only.